BIT's 10th Annual World Cancer Congress -2017 (WCC-2017)
★ Program Layout

Program Layout

Track 1: Opening Ceremony and Keynote Forum

Part 1: Opening Ceremony

Part 2: Keynote Forum

Track 2: Breakthroughs in Cancer Research

Session 201: Molecular Carcinogenesis, Oncogenes and Tumor Suppressors in Cancer

Session 202: Cancer Epigenetics and DNA Methylation

Session 203: Cancer Genetic, Cellular and Tissue Markers

Session 204: Novel Signal Transduction Pathways in Cancer Research

Session 205: Cancer Metabolism and Metabolic Pathways

Session 206: DNA Damage, Repair, Mutagenesis

Session 207: Apoptosis, Autophagy, Necroptosis and Cancers

Session 208: Genomics, Proteomics and Systems Biology

Session 209: MicroRNAs and Long Noncoding RNAs in Cancers

Session 210: Angiogenesis and Anti-angiogenesis in Cancers

Session 211: Circulating, Disseminated Tumor Cells and Metastasis

Session 212: Tumor Microenvironment

Session 213: Cancer Screening, Surveillance and Counseling for High-Risk Populations

Session 214: Cancer Epidemiology, Risk Assessment, and Control

Track 3: Cancer Prognostics and Diagnostics

Session 301: Cancer Prognostic Biomarkers and Predictive Factors

Session 302: Current and Emerging Cancer Diagnostic Technologies and Tests

Session 303: Cancer Molecular Imaging and Nuclear Oncology

Session 304: Molecular Pathology/Cytopathology Approaches, Tissue and Cell-based Cancer Diagnostics

Track 4: Novel Cancer Therapeutics

Session 401: Chemotherapy, Radiotherapy, Photodynamic Therapy, Proton Beam Therapy and Hyperthermia Approaches

Session 402: Cancer Immunotherapy

Session 403: Advanced Targeted Cancer Therapies

Session 404: Gene Therapy, Cell Therapy and Other Cancer Biotherapies

Session 405: Cancer Precision Medicine and Personalized Therapy

Session 406: Combination Therapy, Complementary and Alternative Medicine

Track 5: Latest Anti-cancer Drug Discovery

Session 501: Anti-cancer Drug Delivery, Cancer Drug Design, and Optimization

Session 502: New Cancer Target Identification and Validation

Session 503: Anticancer Drug Clinical Trail

Session 504: Anticancer Drug Candidates Toxicity and Efficacy in Animal Models

Session 505: Anticancer Drugs from TCM and Natural Products

Track 6: Medical Research on Tumors

Session 601: Head, Neck, Brain Cancers, and CNS Tumors

Session 602: Nasopharyngeal, Eye and Oral Cancers

Session 603: Breast Cancer

Session 604: Ovarian and Cervical Cancer and Other Gynecologic Cancer

Session 605: Liver, Cholecyst and Pancreatic Cancer

Session 606: Gastrointestinal Malignancies

Session 607: Lung Cancer

Session 608: Prostate Cancer

Session 609: Melanoma and Other Skin Tumors

Session 610: Leukemia, Lymphoma, and Multiple Myeloma

Session 611: Cancer Rehabilitation, Cancer Nursing and Care

Session 612: Pediatric Cancer

Track 7: Posters and Exhibitions

Posters and Exhibitions

Track 8: Social & Cultural Activities

Activity 1: Welcome Banquet and Art Performance

Activity 2: Industrial Sponsored Cocktail Party

Activity 3: Field Trip to Industry Park/Universities

Activity 4: Impression Tech-Tour in Barcelona


Hosting Organization
World High Technology Society
Operating Organization

BIT Group Global Ltd.

International Honorary Chairman

Dr. Thomas Tursz
Professor & Honorary Director
Institut Gustave Roussy, France

Official Media Partner
Official Travel Agency
BIT’s Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2014-2015 BIT Congress Inc.